title: Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
abstract: The endogenous peptides somatostatin (SRIF) and substance P comprise very different structures. Although both bind G-protein-coupled receptors, the SRIF receptors (SSTR 1-5) recognize SRIF and related peptides which retain its beta-turn such as the potent cyclic hexapeptide SRIF agonist L-363,301 (6a), but not substance P. Conversely the NK-1 receptor binds substance P but not the above ligands. In contrast, the beta-D-glucosides 1 and 2, designed to mimic the beta-turn of 6a, bind both receptors. This observation led us to attempt the conversion of 6a into the first potent, selective cyclic hexapeptide ligand for the NK-1 receptor. To this end, we combined design with a minilibrary approach. The goal was accomplished with surprising ease, leading to the NK-1 receptor antagonist 9 (IC50 2.0 +/- 0.4 nM). This demonstrates that peptidomimetics, incorporating in this case the promiscuous beta-D-glucose scaffold, can provide valuable clues about receptor similarities not revealed by their endogenous ligands. In addition, this work suggests that the use of libraries and rational design need not be mutually exclusive approaches to lead discovery.
authors.affiliation: Department of Chemistry, University of Pennsylvania, Philadelphia 19104, USA.
authors.forename: R
authors.initials: R
authors.lastname: Hirschmann
authors.forename: W
authors.initials: W
authors.lastname: Yao
authors.forename: M A
authors.initials: MA
authors.lastname: Cascieri
authors.forename: C D
authors.initials: CD
authors.lastname: Strader
authors.forename: L
authors.initials: L
authors.lastname: Maechler
authors.forename: M A
authors.initials: MA
authors.lastname: Cichy-Knight
authors.forename: J
authors.initials: J
authors.lastname: Hynes
authors.forename: R D
authors.initials: RD
authors.lastname: van Rijn
authors.forename: P A
authors.initials: PA
authors.lastname: Sprengeler
authors.forename: A B
authors.initials: AB
authors.lastname: Smith
mesh_terms: D000595:Amino Acid Sequence; D002851:Chromatography, High Pressure Liquid; D015195:Drug Design; D005960:Glucosides / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D007295:Inositol Phosphates / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D015394:Molecular Structure; D064729:Neurokinin-1 Receptor Antagonists; D009842:Oligopeptides / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D018040:Receptors, Neurokinin-1 / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000378:metabolism; D013004:Somatostatin / Q000494:pharmacology; D013373:Substance P / Q000378:metabolism / Q000494:pharmacology
chemical_list: D005960:Glucosides; D007295:Inositol Phosphates; D008024:Ligands; D064729:Neurokinin-1 Receptor Antagonists; D009842:Oligopeptides; D010456:Peptides, Cyclic; D018040:Receptors, Neurokinin-1; D017481:Receptors, Somatostatin; C100449:cyclo((2-naphthyl)alanyl-tryptophyl-(4-fluoro)phenylalanyl-threonyl-phenylalanyl-prolyl); D013373:Substance P; D013004:Somatostatin